(Press-News.org) For many patients, radioactive iodine treatment after thyroid cancer surgery means side effects like nausea and time in hospital isolated from loved ones. But new clinical trial results from researchers at UCL mean hundreds of thousands of patients worldwide could now safely be spared this treatment.
Globally, around 820,000 people are diagnosed with thyroid cancer each year. Compared to most cancers, it affects a high proportion of younger people who are more likely to be parents to young children. It is also three times more common in women than men.
The Iodine or Not (IoN) clinical trial, funded by Cancer Research UK and published in The Lancet, sought to determine whether patients with low-risk thyroid cancer could safely forego radioactive iodine treatment following surgery to remove the thyroid, a butterfly-shaped gland in the neck that produces hormones to help regulate metabolism and energy levels.
The trial involved 504 patients aged 17-80 (with 153 aged 40 years or below) from 33 UK cancer centres, whose chances of their thyroid cancer returning were determined to be low. Half were randomly assigned to receive radioactive iodine treatment, which is designed to destroy any remaining cancer cells following surgery. The other half received surgery only.
The patients were assessed regularly for at least five years. By the end of the study, 98% of patients who did not have radioactive iodine were still free from thyroid cancer, compared to 96% who did receive it (though the latter number is lower, the authors say that this is likely down to chance rather than any clinically significant factor).
Professor Allan Hackshaw, an investigator of the trial from UCL Cancer Institute, said: “Our results show that radioactive iodine represents over-treatment in these particular patients and is not required to improve their outcomes. The only impact of not receiving this radiotherapy was a positive one on people’s quality of life.
“This is particularly important because around a third of patients in the study were aged 40 years or less, and many would have children to care for. Not having physical contact can be quite hard for them. Being spared radioactive iodine therapy means they will be able to get back to a near normal life much more quickly, as well as receiving the emotional and physical support of their families in the weeks after their operation.”
The authors estimate that 2,500 patients in the UK and 400,000 patients worldwide could potentially avoid radioactive iodine treatment each year.
Currently, radioactive iodine is considered for most patients following surgical removal of the thyroid gland for cancer. Patients are given this treatment in hospital and must be isolated in a radiation-protected room to avoid contact with people for between one and three days.
Patients are also asked to follow safety precautions for several more days after leaving hospital. This involves avoiding or minimising contact with other people to protect them from any radiation exposure, particularly physical contact with children who are more susceptible to the low level of radioactivity the patient may have.
Dr Ujjal Mallick, an expert oncologist from the Freeman Hospital, Newcastle, who was the trial’s chief investigator, said: “This study represents a major improvement in how thousands of thyroid cancer patients might be treated worldwide. They can avoid the risk of side effects of radioactive iodine treatment such as changes in taste, salivary gland problems, dry mouth, changes in taste, lacrimal gland problems and also the very small risk of a new and different cancer in the future.”
As well as the benefits for patients, foregoing radioactive iodine treatment would mean lower healthcare costs, reducing the pressure on clinical staff and hospital beds. The investigators say that there is no reason why the improved treatment regimen cannot be incorporated into clinical guidelines immediately, in the UK and globally.
Dr Kate Newbold, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust and co-investigator of the study, said: “IoN is an exemplar study that shows that the UK can successfully run major practice-changing clinical trials in cancer – with impacts for patients and healthcare systems internationally.”
Kate Farnell, CEO of Butterfly Thyroid Cancer Trust, said: “On behalf of thyroid cancer patients we are delighted. Many tell us that having radiation treatment in isolation away from their family is perhaps the hardest part of their cancer journey. This trial has shown that in many patients this will no longer be necessary.”
The IoN clinical trial was developed by expert UK oncologists, clinical trial specialists and Butterfly Thyroid Cancer Trust, involving over 30 NHS centres. The trial was conducted by the Cancer Research UK & University College London Cancer Trials Centre, and funded by Cancer Research UK.
Notes to Editors:
For more information, please contact:
Dr Matt Midgley
+44 (0)20 7679 9064
m.midgley@ucl.ac.uk
Publication:
Ujjal Malick et al. ‘Thyroidectomy with or without post-operative radioiodine for low risk differentiated thyroid cancer patients: a UK randomised multicentre noninferiority trial (IoN)’ is published in The Lancet and is strictly embargoed until Wednesday 18 June 2025 at 23:30 BST / 18:30 ET.
DOI: https://doi.org/10.1016/S0140-6736(25)00629-4
About UCL – London’s Global University
UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.
Since 1826, we have championed independent thought by attracting and nurturing the world's best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.
The Times and Sunday Times University of the Year 2024, we are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.
We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.
For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.
We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.
www.ucl.ac.uk | Follow @uclnews on Bluesky | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | View images on Flickr | Find out what’s on at UCL Mind
END
More time with loved ones for cancer patients spared radiation treatment
2025-06-20
ELSE PRESS RELEASES FROM THIS DATE:
New methods speed diagnosis of rare genetic disease
2025-06-20
NEW YORK, NY (June 20, 2025)—A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now help physicians more quickly diagnose patients with suspected genetic disorders of the immune system, many who have been trapped in diagnostic limbo for years.
The researchers, who published their findings June 20 in Cell, applied the method to one rare inborn error of immunity called activated-PI3Kδ syndrome (APDS) and found dozens of additional genetic variations that could cause the syndrome.
“Our findings give physicians a resource that can help them rapidly diagnose and treat ...
Genetics of cardiomyopathy risk in cancer survivors differ by age of onset
2025-06-20
(MEMPHIS, Tenn. – June 20, 2025) The relationship between genetic variants and the risk of late-onset cardiomyopathy remains poorly understood in survivors of childhood cancer despite being otherwise well established. Scientists from St. Jude Children’s Research Hospital have helped address this gap, assessing whether variant trends seen in the general population also apply to late-onset cardiomyopathy in five-year survivors of childhood cancer. The work revealed that, as in the general population, common variants in TTNand BAG3 are associated with reduced late-onset cardiomyopathy ...
Autism inpatient collection releases genetic, phenotypic data for more than 1,500 children with autism
2025-06-20
The Simons Foundation Autism Research Initiative (SFARI) has released phenotypic and genetic data from the Autism Inpatient Collection (AIC), a cohort of more than 1,500 youth participants ages 4 to 20 years old who were hospitalized in one of six child psychiatry units in the United States. The AIC, supported by SFARI and the Nancy Lurie Marks Family Foundation, aimed to engage these individuals, many of whom meet recently proposed criteria for ‘profound autism’ (autism characterized by intellectual disability or minimal language that requires high ...
Targeting fusion protein’s role in childhood leukemia produces striking results
2025-06-20
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia (AML). Standard treatment is often ineffective against AML, a cancer that commonly relapses with poor prognosis, particularly when the disease is fueled by fusion proteins involving NUP98. The researchers documented how these fusions drive disease, discovering a protein complex required to express cancer-promoting genes. When they targeted the complex alone or in combination with another anticancer drug, survival significantly ...
Clear understanding of social connections propels strivers up the social ladder
2025-06-20
PROVIDENCE, R.I. [Brown University] — Climbing the social ladder isn’t simply a matter of popularity. Rather, people in positions of influence are particularly adept at forming “maps” of their social connections, which they navigate to become prominent in their social network, new research shows.
It’s like having a “social superpower,” according to study author Oriel FeldmanHall, an associate professor of cognitive and psychological sciences at Brown University who is affiliated with the University’s Carney Institute for Brain Science.
“People vary ...
New research reveals why acute and chronic pain are so different – and what might make pain last
2025-06-20
A new study reveals that when we experience short-term (acute) pain, the brain has a built-in way to dial down pain signals — like pressing the brakes — to keep them from going into overdrive. But in long-term (chronic) pain, this braking system fails, and the pain signals just keep firing. This discovery helps explain why some pain goes away while other pain lingers, and it opens the door to new treatments that could stop pain from becoming chronic in the first place.
Why does some pain go away ...
Stable cooling fostered life, rapid warming brought death: scientists use high-resolution fusuline data reveal evolutionary responses to cooling and warming
2025-06-20
The Earth is rapidly warming — but did you know? Similar climate upheavals over 300 million years ago once triggered massive fluctuations in marine life.
Recently, a research team led by Prof. Shuzhong Shen of Nanjing University published a major finding in Science Advances, revealing for the first time — through high-precision big data — that during the Late Paleozoic (approximately 340 to 250 million years ago), global cooling promoted rapid evolution and diversification of marine life, while abrupt warming, especially that induced by volcanic eruptions, led to mass extinctions.
The focus of the study is an ancient group of single-celled marine organisms ...
New research casts doubt on ancient drying of northern Africa’s climate
2025-06-20
PROVIDENCE, R.I. [Brown University] — A study led by researchers from Brown University finds that rainfall patterns across northern Africa remained largely stable between 3.5 and 2.5 million years ago — a pivotal period in Earth’s climate history when the Northern Hemisphere cooled, and places like Greenland became permanently glaciated.
The new findings, published in Science Advances, challenge long-held interpretations of the climate history of northern Africa, which had suggested that the region dried out considerably during this period. The timing coincides with the appearance of the first known member of the genus Homo in the fossil record, leading ...
Study identifies umbilical cord blood biomarkers of early onset sepsis in preterm newborns
2025-06-20
Scientists from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago and colleagues identified several proteins from the umbilical cord blood of preterm newborns that signal acute systemic inflammation as an immune response to infection, providing objective and noninvasive means to diagnose early onset sepsis. This finding could spare infants from prolonged exposure to unnecessary antibiotics, which leaves them at risk for subsequent serious infections and dysregulation ...
AI development: seeking consistency in logical structures
2025-06-20
A new perspective on the future development of artificial intelligence (AI) has been put forward by researchers Li Guo and Jinghai Li in their article titled “The Development of Artificial Intelligence: Toward Consistency in the Logical Structures of Datasets, AI Models, Model Building, and Hardware?” published in Engineering. The authors argue that while current AI systems have made significant strides in handling the statistical properties of complex systems, they still face challenges in effectively processing and fully representing the spatiotemporal complexity patterns of these systems.
The paper begins by highlighting the global interest in AI and its potential ...